000 01730cam a2200337 a 4500
003 EG-GiCUC
005 20250223030756.0
008 130224s2012 ua h f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.18.M.Sc.2012.Ma.T
100 0 _aMai Abdelfattah Fayez Megahed
245 1 0 _aThrombopoietin in HCV liver disease and its role in HCV related thrombocytopenia /
_cMai Abdelfattah Fayez Megahed ; Supervised Hala Mahmoud Abdelhamid , Noha Mohammed Elhusseiny
246 1 5 _aالعلاقة بين نقص الصفائح الدموية المصاحب للاصابة بفيروس سي الكبدى المزمن و نقص هرمون الثرومبوبيوتين
260 _aCairo :
_bMai Abdelfattah Fayez Megahed ,
_c2012
300 _a130 Leaves :
_bfacsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine
520 _aEgypt has the largest epidemic of hepatitis C virus (HCV) in the world. Patients with chronic hepatitis C virus (HCV) infection are at risk of a great number of extrahepatic manifestations (EHMs), up to 40-76% of patients infected with HCV develop at least one EHM during the course of the disease. Thrombopoietin is a common finding in subjects with chronic hepatitis
530 _aIssued also as CD
653 4 _aHepatitis C virus
653 4 _aThrombocytopenia
653 4 _aThrombopoietin
700 0 _aHala Mahmoud Abdelhamid ,
_eSupervisor
700 0 _aNoha Mohammed Elhusseiny ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c41683
_d41683